Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Thinkers Wanted: Join the Grassroots Rheumatology Think Tank

David S. Pisetsky, MD, PhD  |  Issue: March 2010  |  March 1, 2010

Not surprisingly, the playing field is not level and the amount of money available for advocacy efforts and political contributions varies enormously in a way that can distort the process. The big players, such as the insurers and pharmaceutical industry, have resources that dwarf those of the organizations of physicians or nurses, for example. When it comes to advocacy groups for patients, the problem is even more severe. Fundraising in the current economy is very tough and these organizations, financially clobbered by the recession, do not have access to enough money to mount state advocacy efforts, especially if future political struggles require a presence in 50 different capitals.

For a democracy to thrive, it vitally needs participation from its citizens, whether that comes in the form of votes, money, or ideas. If the past debate on healthcare is an indication, ideas are at a premium, just as dollars are. This situation is especially true because the field of ideas is crowded, shifting, or chaotic. Indeed, any group engaging in the political process needs a treasure chest of good ideas, including fall-back positions, because the necessity for compromise can knock down positions like duck pins bashed by a careening bowling ball.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Providers are busy people and their minds are elsewhere—mainly on caring for patients. Few have been able to think through political options to establish a full menu of positions beyond the more clear-cut issues such as Medicare reimbursement. In politics, the half-life of an idea can be very short and the rush of the legislative process can demand almost instant reformulation and recalculation. If no single payer, then what? If no public option, then what? The scenario can be switched according to political viewpoint and the ups and downs of deal making and horse trading.

Not surprisingly, the playing field is not level and the amount of money available for advocacy efforts and political contributions varies enormously in a way that can distort the process.

The value of ideas in Washington explains the number and prominence of think tanks. The members of think tanks are often top scholars; in other circumstances, these people would be professors at places like Princeton or Berkeley. While think tankers do important work, their scholarship is not directed to new knowledge but flows from the impetus to justify a position. It should be no surprise that the intellectual output of think tanks has an uncanny relationship to the input in terms of money or the values of the benefactors.

Ideas for Rheumatology

As René Descartes said, “I think, therefore I am.” Therefore, for rheumatology to exist and—better—to thrive as a political being, it has to think. This thought must be deep and wide and concern the full gamut of issues that confront our specialty. A think tank for rheumatology would be a great, but we live in the real world not a political utopia. Our thinking will be a bootstrap, grassroots effort and require as many people and diverse opinions as possible to forge a common vision about healthcare delivery that can transcend the more limited realm of practice and reimbursement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyOpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:AdvocacyHealthcareLegislationPolitics

Related Articles

    PAC a Punch on Capitol Hill

    May 1, 2007

    New political action committee will be a voice for rheumatology

    Ethics Forum: Personal Ethics Questions Surrounding RheumPAC Donations

    October 14, 2015

    Imagine you’ve just heard a compelling presentation urging all ACR members to contribute to RheumPAC, the ACR’s political action committee. RheumPAC’s mission is to support politicians who support issues important to rheumatologists. You are impressed by the role RheumPAC has played in a number of issues you support. Just as you’re writing a check, you…

    Rheumatology Advocacy Starts at Home

    August 1, 2014

    The ACR expands advocacy efforts to impact state legislatures, local organizations

    A Fork in the Road: Advocacy for Rheumatology

    July 10, 2012

    Is that fork bent? So you must be a rheumatologist.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences